Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bortezomib (velcade) (1 trial)
melphalan (alkeran) (1 trial)
propofol (diprivan) (1 trial)
sevoflurane (ultane) (1 trial)
aminoven (1 trial)
renoral (1 trial)
Acute Lung Injury (Phase 3)
Multiple Myeloma (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Syndrome (Phase 3)
Trials (3 total)
Trial APIs (6 total)